Data gathered: April 15
AI Stock Analysis - CVRx (CVRX)
Analysis generated February 13, 2025. Powered by Chat GPT.
CVRx, headquartered in Minneapolis, Minnesota, is a medical device company that specializes in innovative and minimally invasive treatments for cardiovascular diseases. Their flagship product, the Barostim Neo System, is used to treat chronic heart failure and hypertension. CVRx is committed to improving patient outcomes through cutting-edge technology and ongoing research and development efforts.
Stock Alerts - CVRx (CVRX)
 |
CVRx | April 12 Employee Rating is down by 2.6% over the last month. |
|
CVRx | April 10 Price is down by -5.1% in the last 24h. |
|
CVRx | April 9 Price is up by 5% in the last 24h. |
|
CVRx | April 9 Youtube Subscribers are up by 2.2% in the last 24h. |
Alternative Data for CVRx
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 12 | Sign up | Sign up | Sign up |
| Sentiment | 46 | Sign up | Sign up | Sign up |
| Webpage traffic | 9,000 | Sign up | Sign up | Sign up |
| Employee Rating | 74 | Sign up | Sign up | Sign up |
| Google Trends | 17 | Sign up | Sign up | Sign up |
| Patents | 15 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 1 | Sign up | Sign up | Sign up |
| Facebook Followers | 1,629 | Sign up | Sign up | Sign up |
| Instagram Followers | 385 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 71 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 748 | Sign up | Sign up | Sign up |
| Twitter Followers | 947 | Sign up | Sign up | Sign up |
| Twitter Mentions | 11 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 10,000 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 77 | Sign up | Sign up | Sign up |
| Linkedin Employees | 249 | Sign up | Sign up | Sign up |
About CVRx
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases.
| Price | $6.53 |
| Target Price | Sign up |
| Volume | 387,870 |
| Market Cap | $162M |
| Year Range | $6.2 - $18.4 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Medical Devices |
In the news
 |
William Blair Comments on CVRx’s Q1 Earnings (NASDAQ:CVRX)April 12 - ETF Daily News |
|
Norges Bank Purchases New Position in CVRx, Inc. (NASDAQ:CVRX)April 12 - ETF Daily News |
 |
Lake Street Capital Cuts CVRx (NASDAQ:CVRX) Price Target to $14.00April 11 - ETF Daily News |
 |
CVRx Inc: Overreaction Creates Buying OpportunityApril 8 - SeekingAlpha |
 |
Greenbrier, RPM International, CVRx And Other Big Stocks Moving Lower In Tuesday's Pre-Market SessionApril 8 - Biztoc.com |
 |
CVRx price target lowered by $5 at Canaccord, here's whyApril 8 - Thefly.com |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q4 '24 | 15M | 2.3M | 13M | -11M | -14M | -0.430 |
| Q3 '24 | 13M | 2.2M | 11M | -13M | -12M | -0.570 |
| Q2 '24 | 12M | 2M | 9.8M | -14M | -13M | -0.650 |
| Q1 '24 | 11M | 1.7M | 9M | -22M | -21M | -1.040 |
| Q4 '23 | 11M | 1.7M | 9.6M | -9.2M | -8.4M | -0.440 |
Insider Transactions View All
| VERRASTRO PAUL filed to sell 1,875 shares at $13.6. November 21 '24 |
| SLATTERY JOSEPH P filed to buy 30,645 shares at $8.1. August 15 '24 |
| SLATTERY JOSEPH P filed to buy 27,645 shares at $8.2. August 8 '24 |
| SLATTERY JOSEPH P filed to buy 24,645 shares at $9.1. August 6 '24 |
| Hykes Kevin filed to buy 30,000 shares at $8.4. August 5 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Boston ScientificBSX |
$94.27 0% | 72 |
 |
Edwards LifesciencesEW |
$69.87 0% | 32 |
 |
Intuitive SurgicalISRG |
$490.13 0% | 66 |
 |
MedtronicMDT |
$84.22 0% | 47 |
 |
StrykerSYK |
$353.42 0% | 48 |
Read more about CVRx (CVRX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of CVRx?
The Market Cap of CVRx is $162M.
What is the current stock price of CVRx?
Currently, the price of one share of CVRx stock is $6.53.
How can I analyze the CVRX stock price chart for investment decisions?
The CVRX stock price chart above provides a comprehensive visual representation of CVRx's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling CVRx shares. Our platform offers an up-to-date CVRX stock price chart, along with technical data analysis and alternative data insights.
Does CVRX offer dividends to its shareholders?
As of our latest update, CVRx (CVRX) does not offer dividends to its shareholders. Investors interested in CVRx should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of CVRx?
Some of the similar stocks of CVRx are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.